Moreover, SMAD6 was reported to be overexpressed in ovarian adenocarcinoma compared to normal ovarian tissue [27], and expression of BMP-2 protein has been shown to induce SMAD6 expression in ovarian cancer cells and was associated with poor prognosis [28]. This evidence concerns the gene SMAD6 and ovarian cancer.